H. Son Espases

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Acute lymphoblastic leukaemia1 trial
• Chronic lymphocytic leukaemia1 trial
• Crohn's disease1 trial
• Ulcerative colitis1 trial

Phase

• Phase 21 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• PETHEMA Foundation2 trials
• Adacyte Therapeutics SL1 trial

Running trials

• Recruiting

  Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  NCT06544785· Phase 2· PETHEMA Foundation· Source

  Contact: Andrés Novo

• Active, not recruiting

  National GMA Post-market Clinical Follow-up Study (GRACE)

  NCT05636709· Adacyte Therapeutics SL· Source

• Recruiting

  Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults

  NCT04179929· PETHEMA Foundation· Source

  Contact: Andrés Novo

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute lymphoblastic leukaemia1 recruiting
• Chronic lymphocytic leukaemia1 recruiting